Your monthly Portrazza cost savings if eligible
If you are eligible for the Portrazza patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Portrazza through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Portrazza patient assistance program?
You could receive your Portrazza without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Portrazza patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Portrazza.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Portrazza patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Portrazza medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx a Portrazza coupon provider?
At NiceRx, we help eligible individuals access the Portrazza patient assistance program. This means that we are not a Portrazza coupon, a Portrazza discount card, or a Portrazza copay card provider. We do not offer any medication trial offers, or free Portrazza samples.
Can NiceRx help me get Portrazza cheaper if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Portrazza medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Portrazza cost without insurance?
Portrazza costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Portrazza intravenous solution (16 mg/mL) will typically cost around $4,570 for 50 milliliters. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Portrazza cost with insurance?
The copay of Portrazza will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Portrazza?
Portrazza is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Eli Lilly and Company. It is an epidermal growth factor receptor (EGFR) antagonist indicated, in combination with gemcitabine and cisplatin, for the first-line treatment of patients with metastatic squamous non-small cell lung cancer. Portrazza is not indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC).
What doses of Portrazza are available?
Portrazza is available in injection form, in the following doses: 800 mg/50 mL (16 mg/mL) solution in a single-dose vial.
The recommended dose of Portrazza is 800 mg (absolute dose) as an intravenous infusion over 60 minutes on Days 1 and 8 of each 3-week cycle. Continue treatment until disease progression or unacceptable toxicity.
See the full prescribing information and prescription information for the complete boxed warning and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Portrazza active ingredients
Portrazza contains necitumumab as the active ingredient. Its mechanism of action is as an anti-EGFR recombinant human monoclonal antibody of the IgG1 kappa isotype that specifically binds to the ligand-binding site of the human EGFR, which is commonly found on squamous NSCLC tumors. Portrazza is an inhibitor of the activity of the protein EGFR.
Portrazza side effects
The most common side effects of Portrazza in clinical trials include:
- Skin rash
- Dry skin
- Dermatitis acneiform
In rare instances, Portrazza can cause more serious side effects. These can include:
- Cardiopulmonary arrest and/or sudden death – monitor serum electrolytes, including serum magnesium, potassium, and calcium
- Pulmonary embolismHypomagnesemia – monitor for hypomagnesemia, hypocalcemia, and hypokalemia prior to each dose during treatment and for at least 8 weeks following completion. Withhold treatment for Grade 3 or 4 electrolyte abnormalities
- Venous and arterial thromboembolic events (VTE and ATE)
- Dermatologic toxicities – limit sun exposure
- Infusion-related reactions
- Non-Squamous NSCLC – increased toxicity and mortality
- Embryo-fetal toxicity
Your doctor will assess the benefits of using Portrazza against your risk of side effects. Patients are encouraged to report negative side effects or adverse events of Portrazza to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Portrazza drug interactions
Other drugs may interact with Portrazza, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medicines including any supplements you are taking.
You should not use Portrazza if you:
- Are allergic to the active ingredient necitumumab
- Are allergic to any of the other ingredients in Portrazza
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed – breast-feeding is not recommended while using this drug and for 3 months after the last dose
Talk to your doctor before using Portrazza if you:
- Are taking any of the medications that could interact with Portrazza
- Have coronary artery disease
- Have high blood pressure
- Have chronic obstructive pulmonary disease (COPD)
- Have an electrolyte imbalance such as low levels of potassium or magnesium in your blood
- Have a history of heart attacks or stroke
Portrazza is the trademark brand name for necitumumab manufactured by Eli Lilly and Company. A generic version of necitumumab is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Portrazza savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.